Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells
Cell - United States
doi 10.1016/j.cell.2018.10.014
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Elsevier BV